Schedule 13D ownership disclosure

Supernus Pharmaceuticals Inc

Security class unavailable · CUSIP: 868459108

Event date: 2014-05-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,301,645
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001571049-14-001847
Form type
SC 13D
Filer
Discovery Group I, LLC
CIK
CIK 1312548
Filed
May 14, 2014
Reporting period
May 05, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub